Thromboprophylaxis for atrial fibrillation

scientific article published on 01 January 1999

Thromboprophylaxis for atrial fibrillation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(05)74877-7
P698PubMed publication ID10023940

P2093author name stringG Y Lip
P2860cites workA randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering CommitteeQ29620666
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsQ34374902
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerQ42281643
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeQ42551725
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillationQ48940645
Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.Q53352979
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.Q53360138
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialQ56659254
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trialQ68495699
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirinQ71401392
Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on EchocardiographyQ74429767
Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trialsQ74725371
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillationQ77178177
P433issue9146
P407language of work or nameEnglishQ1860
P921main subjectatrial fibrillationQ815819
P304page(s)4-6
P577publication date1999-01-01
P1433published inThe LancetQ939416
P1476titleThromboprophylaxis for atrial fibrillation
P478volume353

Reverse relations

cites work (P2860)
Q28193502A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation
Q34617710Atrial fibrillation and antithrombotic treatment in Italian hospitalized patients: a prospective, observational study
Q28364493Effects of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis
Q28184824Indobufen: an updated review of its use in the management of atherothrombosis
Q73546244Mitral regurgitation and atrial fibrillation: milder the disease, higher the risk?
Q33671179Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin
Q55398440Should atrial fibrillation patients with hypertension as an additional risk factor of the CHA2DS2-VASc score receive oral anticoagulation?
Q28194372Stroke prevention in patients with atrial fibrillation
Q43602937Targeting patients with atrial fibrillation and improving their anticoagulation management
Q37333837The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis
Q77765895Thromboprophylaxis for atrial fibrillation

Search more.